The Spanish Association of Biosimilar Medicines, BioSim, wanted to highlight the relevance of the results of the Guide of the National Institute for Health and Care Excellence (NICE) which announce that drugs such as adalimumab, etanercept and infliximab, previously indicated for severe rheumatoid arthritis, will be prescribed for patients with moderate disease stages.
recently published
Horizon scanning
Jan 31 2024
Early Treatment: the role of biosimilars
18 2023 December
